Evaluation of European severe acute respiratory infection (SARI) surveillance, 27 European countries, 2022/23
Diogo Marques(Public Health Scotland), Angela Rose, Lisa Domegan(Health Service Executive), Dory Kovacs, Susana Monge(Instituto de Salud Carlos III), Ana Paula Rodrigues(Microsoft (Brazil)), Ausenda Machado(National Institute of Health Dr. Ricardo Jorge), Carlos Carvalho(European Centre for Disease Prevention and Control), Clara Mazagatos(Instituto de Salud Carlos III), Joan O’Donnell(Health Service Executive), Baltazar Nunes(University of Lisbon), Hanne‐Dorthe Emborg(Statens Serum Institut), Marco Ruiz, Mariëtte Hooiveld(Netherlands Institute for Health Services Research)
Cited by 3
Related Papers
Ambient Particulate Air Pollution and Daily Mortality in 652 Cities
|New England Journal of Medicine|2019|1.7k
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
|Antimicrobial Agents and Chemotherapy|2001|653
Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
|PLoS Medicine|2011|303